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Abstract
Aims
To investigate seasonality and association of increased enterovirus and influenza activity in
the community with ventricular fibrillation (VF) risk during first ST-elevation myocardial
infarction (STEMI).
Methods
This study comprised all consecutive patients with first STEMI (n = 4,659; aged 18–80
years) admitted to the invasive catheterization laboratory between 2010–2016, at Copenha-
gen University Hospital, Rigshospitalet, covering eastern Denmark (2.6 million inhabitants,
45% of the Danish population). Hospital admission, prescription, and vital status data were
assessed using Danish nationwide registries. We utilized monthly/weekly surveillance data
for enterovirus and influenza from the Danish National Microbiology Database (2010–2016)
that receives copies of laboratory tests from all Danish departments of clinical microbiology.
Results
Of the 4,659 consecutively enrolled STEMI patients, 581 (12%) had VF before primary per-
cutaneous coronary intervention. In a subset (n = 807), we found that VF patients
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experienced more generalized fatigue and flu-like symptoms within 7 days before STEMI
compared with the patients without VF (OR 3.39, 95% CI 1.76–6.54). During the study
period, 2,704 individuals were diagnosed with enterovirus and 19,742 with influenza. No sig-
nificant association between enterovirus and VF (OR 1.00, 95% CI 0.99–1.02), influenza
and VF (OR 1.00, 95% CI 1.00–1.00), or week number and VF (p-value 0.94 for enterovirus
and 0.89 for influenza) was found.
Conclusion
We found no clear seasonality of VF during first STEMI. Even though VF patients had expe-
rienced more generalized fatigue and flu-like symptoms within 7 days before STEMI com-
pared with patients without VF, no relationship was found between enterovirus or influenza
exposure and occurrence of VF.
Introduction
Sudden cardiac death (SCD) caused by ventricular fibrillation (VF) during acute myocardial
infarction (MI) is a major cause of cardiovascular mortality.[1–3] Susceptibility to VF during
acute ischemia is undoubtedly multifactorial and modulated by several factors, including auto-
nomic dysregulation, electrolyte disturbance, hemodynamic dysfunction, inherited factors,
and various environmental influences.[1,4,5]
Seasonal variation has been reported in the incidence of sudden cardiac arrest (SCA) and
sudden death/SCD,[6–10] typically with a winter peak and a summer nadir. Exposure to cold
weather is considered the main factor influencing this seasonality.[7] However, these previous
epidemiological studies are limited by differences in the definition of SCD (none had VF
recording available) used and the fact that they often included SCD cases occurring in the set-
ting of different cardiac pathologies (i.e., etiological heterogeneity in substrate for VF). Never-
theless, these seasonal patterns indicate the presence of seasonal external factors, such as viral
infections, that could trigger VF. While several studies indicate consistent association between
viral infections and MI,[11–13] there is weaker evidence of an association between viral expo-
sure and cardiac arrhythmias and SCA[14,15]. A genome-wide association study in the Dutch
AGNES (Arrhythmia Genetics in the NEtherlandS) population showed that the most signifi-
cant association with VF during first ST-elevation myocardial infarction (STEMI) is localized
at chromosome 21q21 (SNP: rs2824292, odds ratio = 1.78, 95% CI 1.47–2.13, P = 3.3x10-10).
[16] Interestingly, the closest gene to this locus is the CXADR gene, which encodes the cox-
sackie (a member of enterovirus (EV)) and adenovirus receptor (CAR-receptor).[16] Further-
more, electrophysiological studies and molecular analyses on CAR in mice showed that CAR
is a novel modifier of ventricular conduction and arrhythmia vulnerability in the setting of
myocardial ischemia.[17] Moreover, we and others previously showed that SCD victims and
individuals resuscitated from SCA experienced generalized fatigue and influenza-like symp-
toms in the days to weeks before SCD/SCA,[18–20] supporting the role of viral exposure in
susceptibility to VF during an acute MI. Several studies have shown that influenza vaccine pro-
tects against acute MI and heart failure.[21–23] In addition, because EV and influenza epidem-
ics can be accurately and reliably forecast, such forecasts could advise individuals with chest
pain and flu-like symptoms to seek medical care in an early phase during outbreaks.
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In this study, the relationship between monthly/weekly incidence of EV or influenza virus
and the risk of VF during a first STEMI was investigated by correlating Danish surveillance
data of EV and influenza exposure in the general population over a period of almost 7 years
with individual data on VF risk before primary percutaneous coronary intervention (PPCI)
among first STEMI patients.
Methods
Study population
The study population consisted of all consecutive patients aged between 18–80 years with a
first STEMI (n = 4,659) admitted to the invasive catheterization laboratory between January 1,
2010 and October 31, 2016 at the Copenhagen University Hospital, Rigshospitalet. Rigshospi-
talet covers all of eastern Denmark (2.6 million citizens), which corresponds to 45% of the
entire Danish population. The STEMI patients were divided in two groups. The main outcome
was if VF occurred within the first 12 hours of symptoms of STEMI before PPCI. We included
both out-of-hospital and in-hospital cardiac arrest with STEMI and VF (82% out-of-hospital
and 17% during emergency care or in hospital (at arrival)). Patients with out-of-hospital car-
diac arrest were included on admission to the PCI center after resuscitation by trained emer-
gency medical service personnel. VF had to occur before the guided catheter insertion for
PPCI; all VF cases had ECG-documented VF. In addition, all medical reports (emergency and
hospital records) and discharge summaries were reviewed to verify patients as VF cases.
Patients who were non-Danish citizens (n = 180) were excluded.
The study was approved by the Danish Data Protection Agency (No. 2012-58-0004). Regis-
ters were available in an anonymous setup; individual patients were not identifiable because
the personal identification numbers were encrypted. We obtained approval from the Danish
Patient Safety Authority to gain information on medical reports and discharge summaries
(No. 3-3013-2277/1). In Denmark, ethical approval is not required for retrospective, register-
based studies.
Data sources
A unique and permanent personal identification number is assigned to all residents in Den-
mark. This number is used in all Danish health and administrative registries and enables indi-
vidual-level linkage between all nationwide registries unambiguously.
Fig 1 shows the data collection. We used data from the electronic Eastern Danish Heart
Registry comprising detailed clinical data on all consecutive STEMI patients undergoing car-
diac catherization and coronary revascularization in Eastern Denmark. The electronic Eastern
Danish Heart Registry includes detailed clinical data on all patients undergoing coronary angi-
ography, such as baseline demographics, angiographic findings, and procedure characteristics
from the PPCI.[24] All these data were routinely registered by the PCI operator and assistants
in the catheterization laboratory during the PPCI. This registry was further linked to the fol-
lowing three nationwide administrative registries via the personal identification number. (1)
The Danish Civil Registration System contains daily changes in the vital status of all residents,
and no historical data are deleted.[25] (2) The Danish National Patient Registry holds informa-
tion on all admissions to hospitals since 1978 and outpatient visits since 1995, coded according
to the International Classification of Diseases (ICD)-8 and ICD-10.[26] Information on date
of admission, date of discharge, and diagnoses of comorbidities was recorded for every STEMI
patient prior to index STEMI. (3) The Danish Registry of Medicinal Product Statistics, which
registers all prescriptions dispensed from Danish pharmacies since 1995. Each drug is coded
according to the international Anatomical Therapeutic Chemical (ATC) classification system,
Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure
PLOS ONE | https://doi.org/10.1371/journal.pone.0226936 February 26, 2020 3 / 14
and the registry includes data on type of drug, strength, quantity dispensed, and date of dis-
pensing [27], which has been shown to be accurate.[28]
Because we were not able to obtain the actual viral exposure on an individual level for the
study population, we used monthly and weekly virus incidences at the national level as a proxy
for the viral exposure. The virology data were obtained from Statens Serum Institute, a Danish
governmental public health and research institute operating within the Danish Ministry of
Health. We utilized weekly and monthly surveillance data for EV and influenza from the Dan-
ish National Microbiology Database (2010–2016), which captures all positive laboratory test
results conducted at hospital laboratories in Denmark.[29] This surveillance system monitors
national trends in circulating viral infections and collects data on EV and influenza at the
Fig 1. Study population selection and data collection.
https://doi.org/10.1371/journal.pone.0226936.g001
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genotype level, as well as patient demographic information and clinical details, including
symptoms and date of symptom onset. During the study period of 82 months, 2,704 individu-
als were diagnosed with EV in the general population. Due to higher incidence of influenza,
we calculated the number of influenza events per week, and during the study period of 358
weeks, 19,742 individuals were diagnosed with influenza. The weekly and monthly viral expo-
sure data were then combined and merged with the Eastern Danish Heart Registry using the
date of PPCI (Fig 1). The data points comprised monthly and weekly counts of individuals
who tested positive for EV and influenza, respectively, obtained from patients who presented
to GPs, as well as from hospitalized patients.
Statistical analysis
Patient characteristics at index STEMI are summarized as the mean and standard deviation
(SD) or proportion according to VF status and compared with t-tests and chi-square tests as
appropriate.
Separate multivariable logistic regressions were performed for the association of EV and
influenza exposure on the day of STEMI and the risk of VF. The models included EV and
influenza incidences as continuous variables and were adjusted for week number as a nominal
variable with 52 levels and calendar year. Moreover, we performed a full adjusted model,
including, week number, calendar year, as well as sex, age, hypertension, atrial fibrillation
(AF), chronic kidney disease, Killip class, culprit lesion, preprocedural TIMI-flow, smoking,
and previous history of angina. Reported were odds ratios (OR) and accompanying 95% confi-
dence intervals (CI). The likelihood ratio test was used to test the significance of week number.
In a subset of patients (n = 807),[30] we had detailed data on whether the patient had expe-
rienced generalized fatigue and flu-like symptoms within the last week prior to the STEMI. A
logistic regression model was fitted on this subset. The model was adjusted for week number,
calendar year, sex, age, hypertension, AF, chronic kidney disease, Killip class, culprit lesion,
preprocedural TIMI-flow, smoking, and previous history of angina.
Analyses were performed using SAS (version 9.4, SAS Institute Inc, Cary, NC, USA) and R.
[31]
Results
Clinical characteristics
Between January 2010 and October 2016, there were 4,659 consecutively enrolled first STEMI
patients (age 18–80 years) at Rigshospitalet in Copenhagen, of whom 581 (12%) had VF before
PPCI. The clinical characteristics at the time of STEMI are shown in Table 1. Patients with VF
were more likely to be men, be a current smoker, have a history of AF and experience no
angina compared with STEMI patients without VF. Furthermore, the proportion on anticoag-
ulant therapy was higher among patients with VF compared with patients without, likely due
to the higher degree of AF (Table 1). The angiographic and other presenting characteristics at
the time of STEMI according to VF status are outlined in Table 1. Patients with VF had shorter
times from symptom onset to PPCI, lower left ventricular ejection fraction, were more likely
to have anterior infarctions with left anterior descending artery occlusions, and had lower pre-
PCI TIMI flow and higher Killip class.
Seasonality of infections and VF during first STEMI
During the study period in the general population, 2,704 individuals were diagnosed with EV
and 19,742 with influenza. Graphs of seasonal patterns of influenza and EV and number of VF
Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure
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Table 1. Patient characteristics at index ST-elevation myocardial infarction according to ventricular fibrillation.
Variable STEMI with VF (n = 581) STEMI without VF (n = 4078) P-value
Sex, men, n (%) 468 (80.6) 3113 (76.3) 0.028
Age at STEMI, years, mean (SD) 59.9 (10.3) 60.7 (10.9) 0.079
Age category, n (%)
<35 <5 36 (0.9) 0.374
35–49 110 (18.9) 697 (17.1)
50–64 263 (45.3) 1790 (43.9)
> = 65 205 (35.3) 1555 (38.1)
BMI, kg/m2, mean (SD) 27.9 (14.5) 27.3 (9.9) 0.267
Missing, n 87 120
Smoking, n (%)
Current 285 (56.8) 1899 (51.1) 0.025
Never 96 (19.1) 894 (24.1)
Past 121 (24.1) 921 (24.8)
Missing, n 79 364
Family history of ischemic heart disease, n (%) 190 (70.1) 2312 (65.5) 0.143
Missing, n 310 550
Canadian Cardiovascular Society (CCS) grading of angina pectoris, n (%)
CCS I-II 33 (7.6) 445 (11.2) 0.032
CCS III-IV 12 (2.8) 72 (1.8)
No angina 390 (89.7) 3462 (87.0)
Missing, n 146 99
COMORBIDITIES
Hypertension, n (%) 100 (17.2) 620 (15.2) 0.233
Diabetes, n (%) 40 (6.9) 328 (8.0) 0.375
Atrial fibrillation, n (%) 33 (5.7) 102 (2.5) < 1e-04
Hypercholesterolemia, n (%) 26 (4.5) 238 (5.8) 0.218
Peripheral vascular disease, n (%) 22 (3.8) 103 (2.5) 0.105
Stroke, n (%) 19 (3.3) 122 (3.0) 0.812
Congestive heart failure, n (%) 15 (2.6) 86 (2.1) 0.562
Chronic kidney disease, n (%) 10 (1.7) 98 (2.4) 0.382
Liver disease, n (%) 9 (1.5) 61 (1.5) 1.000
Malignancy, n (%) 39 (6.7) 367 (9.0) 0.080
PHARMACOTHERAPY—3 months before
Renin-angiotensin-system blockers, n (%) 113 (19.4) 728 (17.9) 0.379
Statins, n (%) 63 (10.8) 444 (10.9) 1.000
Calcium channel blockers, n (%) 61 (10.5) 440 (10.8) 0.889
Antidiabetics, n (%) 40 (6.9) 351 (8.6) 0.187
Beta-blockers, n (%) 59 (10.2) 328 (8.0) 0.100
Acetylsalicylic acid, n (%) 42 (7.2) 290 (7.1) 0.987
Diuretics (combi), n (%) 37 (6.4) 254 (6.2) 0.969
Thiazide, n (%) 35 (6.0) 233 (5.7) 0.837
Loop diuretics, n (%) 20 (3.4) 98 (2.4) 0.177
Potassium supplements, n (%) 16 (2.8) 85 (2.1) 0.376
Anti-coagulantia, n (%) 26 (4.5) 69 (1.7) < 1e-04
Anti-adrenergic drugs, n (%) <5 58 (1.4) 0.211
Spironolactone, n (%) 6 (1.0) 26 (0.6) 0.418
PPCI VARIABLES
(Continued)
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cases in the setting of first STEMI over the study time are shown in Fig 2. Influenza showed
strong winter and spring seasonality (week 40 to week 20), with a maximum observed during
the first 10 weeks of the year. EV was detected year-round but tended to peak, as expected, dur-
ing late summer and fall months. There was no clear seasonality of VF during STEMI.
Results from the logistic regression analyses for VF before PPCI are summarized in Fig 3.
We found no association between EV and VF (OR 1.00, 95% CI 0.99–1.02) or influenza and
VF (OR 1.00, 95% CI 1.00–1.00). We also found no association between week number and VF
(p-value 0.94 for EV model and 0.89 for influenza model), confirming the lack of seasonality
in the risk of VF found in Fig 2.
Subanalysis–generalized fatigue and flu-like symptoms prior to event
In a subset of the patients (n = 807),[30] we had detailed data on whether the patient had expe-
rienced generalized fatigue and flu-like symptoms within the last week prior to the STEMI.
Compared with the STEMI patients without VF prior to PPCI (n = 520), the VF cases
(n = 287) had significantly more generalized fatigue and flu-like symptoms within 7 days
before STEMI (14% vs. 5%, p<0.0001, OR 3.39, 95% CI 1.76–6.54). In addition, the majority
of the symptoms were reported for STEMI patients during influenza season (defined as week
40 to week 20) (76% vs. 24%, p = 0.024).
Discussion
Main findings
This cohort study is the first to investigate the relationship between viral exposure and VF risk
at first STEMI before PPCI. The study consecutively enrolled 4,659 patients with STEMI (aged
Table 1. (Continued)
Variable STEMI with VF (n = 581) STEMI without VF (n = 4078) P-value
Time from symptom onset to PPCI, min, mean (SD) 172.0 (146.8) 268.1 (503.8) < 1e-04
Missing, n 30 93
Pre-procedural LVEF, n (%)
LVEF < = 35 142 (24.4) 238 (5.8) < 1e-04
LVEF >35 189 (32.5) 895 (21.9)
Missing 250 (43.0) 2945 (72.2)
Infarct location, n (%)
Anterior 262 (45.1) 1616 (39.6) < 1e-04
Non-anterior 212 (36.5) 2213 (54.3)
Missing, n 107 249
Culprit lesion, n (%)
LAD 302 (54.1) 1732 (42.6) < 1e-04
Non-LAD 256 (45.9) 2336 (57.4)
Missing 23 10
Pre-procedural TIMI flow, n (%)
TIMI 0-I 21 (3.8) 87 (2.2) 0.015
TIMI II-III 172 (31.2) 1478 (36.6)
Missing, n 30 40
Killip class, n (%)
Killip Class I 454 (83.0) 3711 (94.6) < 1e-04
Killip Class >I 93 (17.0) 213 (5.4)
Missing, n 34 154
https://doi.org/10.1371/journal.pone.0226936.t001
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18–80 years), of whom 12% developed VF prior to PPCI. It was found that VF patients had
experienced more generalized fatigue and flu-like symptoms within 7 days before STEMI com-
pared with the patients without VF (OR 3.39, 95% CI 1.76–6.54). The expected winter peak
and summer nadir of VF were not observed. After correlating Danish viral exposure surveil-
lance data with individual data on VF risk among first STEMI, no such relationship was found
between EV or influenza exposure and occurrence of VF. Therefore, there is no support for an
association between higher levels of EV or influenza and high VF prevalence.
Fig 2. Number of influenza, enterovirus (EV) and ventricular fibrillation (VF) cases per week and month by year.
https://doi.org/10.1371/journal.pone.0226936.g002
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Seasonality of VF and association with viral infections
The seasonality of MI, ventricular arrhythmias, and SCA/SCD has for many decades been the
focus of epidemiology studies, as seasonality may suggest etiological factors.[6–10] Because all
patients in our study had a first STEMI, we were able to examine the seasonality and relation-
ship of viral exposure with VF independently of its association with STEMI. Most,[8,32] but
not all,[33] studies showed a seasonal variation of SCD, with a peak in winter (December and
January) and a reduction during the summer months (from June through September). A link
between viral infection of the heart (myocarditis) and sudden cardiac death has long been rec-
ognized.[34] At least 20 different viruses, including EV, have been implicated in myocarditis.
[35] Although most patients infected with EV remain asymptomatic or only experience flu-
like symptoms, the role of EV as one of the most common causes of viral myocarditis is well-
established.[36] Evidence for a role of EV infection in the modulation of cardiac electrical
function and pro-arrhythmia is the fact that myocarditis is one of the most common findings
at autopsy in young adults who died of SCD,[37] and patients with serious ventricular arrhyth-
mias and survivors of SCD had prevalent detection of EV RNA in their endomyocardial biop-
sies, suggesting a role of EV in ventricular arrhythmias and SCD[38]. Although we did not
find an association between influenza and VF risk during STEMI, substantial evidence has
been gathered to support the effect of influenza among MI patients.[13,39] These findings are
consistent across studies using various measures for viral exposure, such as influenza activity
at the population level through surveillance data,[40,41] as well as at the individual level with
laboratory-confirmed infection[13]. The latter is preferable, and Kwong et al. found in a self-
controlled case-series study that laboratory-confirmed influenza in the week before MI was
associated with increased risk of MI.[13] Incidence ratio for acute MI during the 7-day risk
interval compared with the control interval was 6.05 (95% CI 3.86–9.50). These data suggest
that influenza-like illness can cause MI.[13]
In support of a role for viral infection in the modulation of VF susceptibility, a common
variant genome-wide association study in the Dutch AGNES population, which compared
individuals with and without VF in the setting of a first acute STEMI,[16] identified a VF sus-
ceptibility locus at chromosome 21q21 (rs2824292) close to the CXADR gene. While this
observation is intriguing, the association was not replicated in two similar MI populations.
[42,43] The lack of replication might have been due to the necessity of exposure to EV that
may vary by location and time of the year. However, CAR protein has a long-recognized role
as viral receptor in the pathogenesis of viral myocarditis,[44] a physiologic role for the receptor
Fig 3. Odds ratio for ventricular fibrillation during first ST-elevation myocardial infarction.
https://doi.org/10.1371/journal.pone.0226936.g003
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in localization of connexin 45 at the intercalated disks of the cardiomyocytes in the atrioven-
tricular node, and a role in conduction of the cardiac impulse [17,45,46].
Although there is substantial evidence supporting the role of influenza in CVD mortality
and SCA/SCD,[15,47] we did not find an association between influenza and VF risk during
STEMI. There are several possible reasons for this discrepancy in associations. First, many
studies were designed to investigate overall influenza mortality or CVD mortality rather than
SCA/SCD[47]. Second, most studies included different cardiac causes of SCA and SCD with
consequent etiological heterogeneity, and no study has specifically investigated VF in the set-
ting of an acute first MI. The role of influenza infection may be different with different under-
lying cardiac causes of SCA/SCD. Lastly, some studies used SCA/SCD as a surrogate of VF,
and thus some cases of sudden death due to bradyarrhythmic or noncardiac causes may have
been misclassified.
Strength and limitations
There are several strengths of the current study. Our data collection process was comprehen-
sive, and we were able to adjust the VF risk for multiple significant covariates. Despite these
strengths, there were also some limitations that should be noted. First, we did not have individ-
ual viral exposure data. Second, it employed an ecological study design. As such, it was not
possible to examine the exact exposure history of each individual. In addition, the community
burden of viral infections is substantially underestimated in surveillance data, as most patients
with EV or influenza do not seek medical care. However, because the underreporting is
unlikely to vary over time, there is no evidence that this would substantially bias our results.
Furthermore, the EV incidence was on a monthly basis, and an option could have been to
interpolate the EV data as weekly incidences. However, the data points for EV were too scarce
to obtain reliable incidence estimates. Third, there is a concern for recall bias regarding the
symptoms prior to event. Patients were questioned about their symptoms during the admis-
sion to hospital. However, we have previously found that cases experience less angina within
the last 12 months compared with controls.[30] Fourth, even though data were prospectively
collected, we performed retrospective analyses. Fifth, patients who died outside of hospitals
were not included, and the results may not be generalizable to patients who do not survive to
reach the hospital. Lastly, although the strength of this study is the completeness of data via
link between clinical data (the Eastern Danish Heart Registry) and Danish nationwide regis-
tries the validity of our data depends largely on the accuracy of coding. It has been documented
that the coding of risk factors has high validity and specificity in the Danish National Patient
Registry.[26]
In this study, we focused on seasonal viral infections, but several other CVD risk factors dis-
play seasonal variation. Obesity, increased fat intake, reduced physical activity, and higher
blood pressure and serum cholesterol levels are more prevalent in winter. However, traditional
risk factors including hypertension, hypercholesterolemia, and smoking were not indepen-
dently associated with VF risk during STEMI in our cohort.[24,30] Future studies should base
infection status on the individual STEMI patient to detect whether active infection might
increase risk for VF during acute STEMI.
Clinical implications
Due to low survival after VF and the risk of neurological deficits in patients who survive car-
diac arrest, prevention is key in addressing this important public health problem. In this study,
14% of the VF cases experienced flu-like symptoms during the week before their sudden
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cardiac arrest, and these symptoms may provide an opportunity for medical intervention to
prevent some cases of VF during acute ischemia, especially in high-risk patients.
Conclusion
There was no clear seasonality of VF during STEMI; after correlating Danish viral exposure
surveillance data with individual data on VF risk among first STEMI, no relationship was
found between EV or influenza exposure and occurrence of VF. Even though we found that
VF patients experienced more generalized fatigue and flu-like symptoms within 7 days before
STEMI compared with the patients without VF, our data do not support the hypothesis that
higher levels of EV and influenza are associated with high VF prevalence.
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